Findings indicate blood group A elevates the risk of primary biliary cholangitis, suggesting ABO group analysis could aid in ...

ABO-101 is Abeona's second AAV gene therapy to commence clinical trials in a rare CNS disease The clinical trial is a Phase 1/2 dose escalation study of ABO-101 in 6-9 patients A Natural History Study ...

CAMBRIDGE, Mass., July 30, 2025 (GLOBE NEWSWIRE) -- Arbor Biotechnologies, Inc., a biotechnology company discovering and developing the next generation of genetic medicines, today announced the first ...

The evolution of breast cancer screening in the Medicare population: Clinical and economic implications. This is an ASCO Meeting Abstract from the 2012 ASCO Annual Meeting I. This abstract does not ...

Researchers from the Boston University School of Public Health in the United States say there is no evidence to support a correlation between ABO blood group and the risk of infection with severe ...

- ABO-101 was well tolerated with no serious adverse events or dose-limiting toxicities reported in the 28-days following dosing - Phase 1/2 redePHine study (NCT06839235) dose escalation ongoing with ...

The effect of family history on adherence to breast cancer screening guidelines. This is an ASCO Meeting Abstract from the 2012 ASCO Annual Meeting I. This abstract does not include a full text ...